NO973646D0 - Orale doseringsformer inneholdende et <beta>-laktam antibiotikum - Google Patents

Orale doseringsformer inneholdende et <beta>-laktam antibiotikum

Info

Publication number
NO973646D0
NO973646D0 NO973646A NO973646A NO973646D0 NO 973646 D0 NO973646 D0 NO 973646D0 NO 973646 A NO973646 A NO 973646A NO 973646 A NO973646 A NO 973646A NO 973646 D0 NO973646 D0 NO 973646D0
Authority
NO
Norway
Prior art keywords
pct
beta
lactam antibiotic
granulate
oral dosage
Prior art date
Application number
NO973646A
Other languages
English (en)
Other versions
NO319993B1 (no
NO973646L (no
Inventor
Gerrit Subrands
Robertus Cornelis Van Koutrik
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of NO973646D0 publication Critical patent/NO973646D0/no
Publication of NO973646L publication Critical patent/NO973646L/no
Publication of NO319993B1 publication Critical patent/NO319993B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
NO19973646A 1995-02-08 1997-08-07 Fremgangsmate for fremstilling av et granulat omfattende <beta>-laktam-antibiotikum, hurtig-desintgrerende,oral doseringsform amt fremgangsmate for fremstilling av denne- NO319993B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200313 1995-02-08
PCT/EP1996/000547 WO1996024337A1 (en) 1995-02-08 1996-02-08 ORAL DOSAGE-FORMS CONTAINING A β-LACTAM ANTIBIOTIC

Publications (3)

Publication Number Publication Date
NO973646D0 true NO973646D0 (no) 1997-08-07
NO973646L NO973646L (no) 1997-09-11
NO319993B1 NO319993B1 (no) 2005-10-10

Family

ID=8220003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973646A NO319993B1 (no) 1995-02-08 1997-08-07 Fremgangsmate for fremstilling av et granulat omfattende <beta>-laktam-antibiotikum, hurtig-desintgrerende,oral doseringsform amt fremgangsmate for fremstilling av denne-

Country Status (19)

Country Link
US (1) US5948422A (no)
EP (1) EP0801559B1 (no)
CN (1) CN1125636C (no)
AT (1) ATE216576T1 (no)
AU (1) AU4789696A (no)
BG (1) BG63528B1 (no)
BR (1) BR9607189A (no)
CZ (1) CZ293718B6 (no)
DE (1) DE69620866T2 (no)
DK (1) DK0801559T3 (no)
EA (2) EA000361B1 (no)
ES (1) ES2175073T3 (no)
HU (1) HU227938B1 (no)
MX (1) MX9706062A (no)
NO (1) NO319993B1 (no)
PL (1) PL186386B1 (no)
PT (1) PT801559E (no)
WO (1) WO1996024337A1 (no)
ZA (1) ZA961018B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
CN1225583A (zh) 1996-07-16 1999-08-11 吉斯特-布罗卡迪斯有限公司 无有机溶剂的β－内酰胺颗粒
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
EP1058538B9 (en) * 1998-03-06 2013-01-02 Aptalis Pharma S.r.l. Fast disintegrating tablets
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
CA2423329A1 (en) * 2000-09-22 2003-03-20 Takeda Chemical Industries, Ltd. Solid preparations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
KR20030094244A (ko) * 2001-02-05 2003-12-11 알.피.쉐러 테크놀러지즈 인코포레이티드 약리학적 활성제의 맛을 감소시키기 위한 방법 및 조성물
MXPA04008720A (es) * 2002-03-12 2004-12-06 Squibb Bristol Myers Co Suspension oral de sabor agradable y metodo.
EP1555024B1 (en) * 2002-10-02 2010-09-29 Meiji Seika Kaisha Ltd. Antibacterial medicinal composition of enhanced oral absorptivity
ATE359075T1 (de) * 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
EP1648380B1 (en) * 2003-07-03 2015-04-08 Sertoli Technologies, LLC Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
EP1951207A2 (en) * 2005-11-17 2008-08-06 Novartis AG Pharmaceutical composition
WO2007104573A2 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
JP2010500871A (ja) * 2006-07-28 2010-01-14 セルトセル・バイオテクノロジー・（ユーエス）・コーポレイション 成熟セルトリ細胞およびその使用
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
EP2367422A4 (en) * 2008-12-17 2013-01-09 Altheus Therapeutics Inc FORMULAS FOR LAVATION
WO2023204773A1 (en) * 2022-04-20 2023-10-26 Bilim Ilac Sanayii Ve Ticaret A.S. Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables
DE2251250C3 (de) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten
DE2251249A1 (de) * 1972-10-19 1974-05-02 Hoechst Ag Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
AU715177B2 (en) * 1994-04-13 2000-01-20 Research Corporation Technologies, Inc. Methods of treating disease using sertoli cells and allografts or xenografts
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
CZ230297A3 (en) 1997-11-12
US5948422A (en) 1999-09-07
PL186386B1 (pl) 2004-01-30
AU4789696A (en) 1996-08-27
HU227938B1 (en) 2012-06-28
BR9607189A (pt) 1997-11-11
PL321567A1 (en) 1997-12-08
EA000361B1 (ru) 1999-06-24
DE69620866D1 (de) 2002-05-29
PT801559E (pt) 2002-09-30
EA003736B1 (ru) 2003-08-28
MX9706062A (es) 1997-10-31
ATE216576T1 (de) 2002-05-15
ZA961018B (en) 1997-08-08
BG101822A (en) 1998-04-30
CN1125636C (zh) 2003-10-29
DE69620866T2 (de) 2003-02-27
HUP9801677A3 (en) 1999-05-28
NO319993B1 (no) 2005-10-10
EA199700093A1 (ru) 1998-02-26
DK0801559T3 (da) 2002-06-17
CN1173816A (zh) 1998-02-18
WO1996024337A1 (en) 1996-08-15
NO973646L (no) 1997-09-11
EP0801559A1 (en) 1997-10-22
HUP9801677A2 (hu) 1998-11-30
CZ293718B6 (cs) 2004-07-14
EP0801559B1 (en) 2002-04-24
BG63528B1 (bg) 2002-04-30
ES2175073T3 (es) 2002-11-16
EA199900205A1 (ru) 2000-06-26

Similar Documents

Publication Publication Date Title
NO973646D0 (no) Orale doseringsformer inneholdende et &lt;beta&gt;-laktam antibiotikum
MY116124A (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
ZA965237B (en) A composition and a process for the preparation thereof
DE59510740D1 (de) Pharmazeutische zubereitung enthaltend metformin und verfahren zu deren herstellung
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
HU9503401D0 (en) Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
NO971986D0 (no) Fremgangsmåte for fremstilling av små partikler
IL115920A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION
PT847273E (pt) Composicao farmaceutica melhorada de resina de permuta ionica
NO307594B1 (no) Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat
WO1997010810A3 (en) Pharmaceutical granules
PT89105A (pt) Processo para a preparacao de composicoes farmaceuticas contendo tetraciclina
IL64839A (en) N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them
TW334424B (en) L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them
UY24851A1 (es) Derivados de ácidos n-acil-alfa-aminados

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees